Decades of research have established that the neuropathology of AD results from the accumulation of extracellular amyloid-beta (Aβ) peptides and intracellular neurofibrillary tangles (NFTs) of hyperphosphorylated tau (p-Tau) [3–5]. The gene discussed is MAPT; the disease is Alzheimer disease.